A to Z / Metabolic / weight loss
5-Amino-1MQ
Also known as NNMT inhibitor, 5-amino-1-methylquinolinium.
Best known for An oral compound studied for fat loss, often grouped with peptides
Evidence★☆☆☆☆
Safety dataLargely unknown
Route Oral
United StatesNot approved
AustraliaNot listed by name; unapproved therapeutic good
as at 16 September 2026
What it is
5-Amino-1MQ is an oral compound that inhibits an enzyme called NNMT. It is a small molecule rather than a peptide, but it is often discussed alongside peptides as a fat-loss compound. It is at the animal research stage.
What the full entry covers
The book carries the rest of this entry:
- Where the research stands, with every claim cited
- What people commonly ask, and what the research shows so far
- Dosing in four labelled bands, described and not recommended
- Side effects, serious risks, cautions and interactions
- Questions to discuss with your doctor
- How it compares with AOD-9604, Semaglutide, NAD+ and Precursors, MOTS-c
Related entries
A certificate of analysis tells you what is in a vial. The evidence rating above tells you whether the compound has been shown to work in humans. Neither answers the other's question. How to read a certificate of analysis.
This page describes what is known and not known about 5-Amino-1MQ. It is not medical advice and not a recommendation to use it.